- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
极度弱势行情中，投资者可暂时观望。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有220家主力机构披露2025-06-30报告期持股数据，持仓量总计5.20亿股，占流通A股55.26%
- 波段诊断：
-
技术面诊股
诊断结果：5.6技术面打败了24%的股票
技术面评分前10的股票
近期的平均成本为15.70元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为15.70元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.70","date":1761810667,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.10.31","stock":"0.90","trade":"4.09","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.83","trade":"-0.83","ind":"-1.16"},{"date":"2025.10.29","stock":"-2.30","trade":"1.00","ind":"1.95"},{"date":"2025.10.28","stock":"0.06","trade":"0.24","ind":"-0.44"},{"date":"2025.10.27","stock":"-1.71","trade":"0.61","ind":"1.51"},{"date":"2025.10.24","stock":"0.06","trade":"0.39","ind":"2.02"},{"date":"2025.10.23","stock":"0.62","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"0.12","trade":"-0.28","ind":"-0.62"},{"date":"2025.10.21","stock":"0.37","trade":"1.45","ind":"2.06"},{"date":"2025.10.20","stock":"-0.98","trade":"0.44","ind":"0.98"},{"date":"2025.10.17","stock":"-0.31","trade":"-1.55","ind":"-3.04"},{"date":"2025.10.16","stock":"0.92","trade":"0.01","ind":"-0.25"},{"date":"2025.10.15","stock":"0.43","trade":"2.13","ind":"1.73"},{"date":"2025.10.14","stock":"-0.12","trade":"-1.02","ind":"-2.54"},{"date":"2025.10.13","stock":"-0.61","trade":"-1.02","ind":"-0.93"},{"date":"2025.10.10","stock":"-0.37","trade":"-0.88","ind":"-2.70"},{"date":"2025.10.09","stock":"1.05","trade":"-0.38","ind":"1.47"},{"date":"2025.09.30","stock":"0.19","trade":"0.69","ind":"0.35"},{"date":"2025.09.29","stock":"-1.28","trade":"0.77","ind":"2.05"},{"date":"2025.09.26","stock":"-1.74","trade":"-1.00","ind":"-1.76"},{"date":"2025.09.25","stock":"-1.36","trade":"-0.53","ind":"0.67"}]
派林生物,深证成指,生物制品指数
压力支撑
该股压力位为15.64元，支撑位为15.54元。
[{"text":"\u538b\u529b\u4f4d","value":"15.64","date":1761840000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.54","date":1761840000,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.8资金面打败了25%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：10月31日 20:30
| 机构今日流向(万元) | 4164.89 | 机构5日流向(万元) | 2769.85 |
| 机构10日流向(万元) | -602.62 | 机构20日流向(万元) | -8963.07 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加12462.90万股，其中基金净增仓34家，主力净减仓49家，请投资者中长期谨慎为宜。
截止2025-06-30，共220家主力机构（基金212家，一般法人7家，社保基金1家），持仓量总计51984.18万股，占流通A股55.26%
其中，基金持仓与2024-12-31相比：
增仓：73家 ，增持 1136.50万股
减仓：39家 ，减持 2460.64万股
新出现在主力名单中：95家 ，持有5723.62万股
从主力名单中消失：144家 ，原持有4275.21万股
其中，基金持仓与2024-12-31相比：
增仓：73家 ，增持 1136.50万股
减仓：39家 ，减持 2460.64万股
新出现在主力名单中：95家 ，持有5723.62万股
从主力名单中消失：144家 ，原持有4275.21万股
消息面诊股
诊断结果：5.5消息面打败了4%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 派林生物：10月30日获融资买入1606.42万元
2025-10-31 - 派林生物：10月29日获融资买入3345.03万元
2025-10-30 - 派林生物：10月28日获融资买入878.47万元
2025-10-29 - 股东追踪|吴世军新进派林生物前十大流通股东
2025-10-29 - 财报速递：派林生物2025年前三季度净利润3.57
2025-10-31 - 派林生物：第三季度净利润为1.21亿元，下降43.
2025-10-28 - 派林生物：10月27日获融资买入2169.30万元
2025-10-28 - 派林生物：10月24日获融资买入835.37万元
2025-10-27 - 券商观点|医药生物行业周报：十年维度看，CDMO的
2025-10-27 - 派林生物：10月23日获融资买入857.07万元
2025-10-24
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-29 |
| 一般消息 | 募资投向 | 2025-10-28 | |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-05-12 |
| 利好 | 分红转增 | 10转3股派3.5元(含税) | 2025-04-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.0行业面打败了88%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2025.10.31","price":"-1.14","value":"4.09"},{"date":"2025.10.30","price":"-1.16","value":"-0.83"},{"date":"2025.10.29","price":"1.95","value":"1.00"},{"date":"2025.10.28","price":"-0.44","value":"0.24"},{"date":"2025.10.27","price":"1.51","value":"0.61"},{"date":"2025.10.24","price":"2.02","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.62","value":"-0.28"},{"date":"2025.10.21","price":"2.06","value":"1.45"},{"date":"2025.10.20","price":"0.98","value":"0.44"},{"date":"2025.10.17","price":"-3.04","value":"-1.55"},{"date":"2025.10.16","price":"-0.25","value":"0.01"},{"date":"2025.10.15","price":"1.73","value":"2.13"},{"date":"2025.10.14","price":"-2.54","value":"-1.02"},{"date":"2025.10.13","price":"-0.93","value":"-1.02"},{"date":"2025.10.10","price":"-2.70","value":"-0.88"},{"date":"2025.10.09","price":"1.47","value":"-0.38"},{"date":"2025.09.30","price":"0.35","value":"0.69"},{"date":"2025.09.29","price":"2.05","value":"0.77"},{"date":"2025.09.26","price":"-1.76","value":"-1.00"},{"date":"2025.09.25","price":"0.67","value":"-0.53"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华兰疫苗 | 31.75% | 8.99% | 5.8分 |
| 2 | 三生国健 | 29.16% | 33.07% | 7.0分 |
| 3 | 我武生物 | 19.20% | 3.19% | 5.5分 |
| 4 | *ST双成 | 17.02% | 3.48% | 5.7分 |
| 5 | - | 15.22% | 2.24% | 分 |
| 6 | 金迪克 | 11.68% | 3.28% | 6.1分 |
| 8 | - | 9.99% | 13.99% | 分 |
| 10 | *ST四环 | 8.85% | -5.38% | 5.0分 |
| 12 | 赛升药业 | 8.35% | 5.95% | 5.3分 |
| 14 | 安科生物 | 8.13% | 8.34% | 6.5分 |
| 16 | 科兴制药 | 6.58% | 11.29% | 7.2分 |
| 18 | 赛伦生物 | 6.09% | 4.86% | 6.1分 |
| 20 | 康华生物 | 5.20% | 7.28% | 5.9分 |
| 22 | 百普赛斯 | 4.20% | 2.29% | 5.3分 |
| 24 | 凯因科技 | 3.88% | 3.21% | 6.3分 |
| 26 | 华兰生物 | 3.60% | -0.62% | 5.8分 |
| 28 | 卫光生物 | 3.16% | 0.22% | 5.2分 |
| 30 | 博晖创新 | 2.86% | 0.17% | 5.5分 |
| 32 | 康希诺 | 1.58% | 6.18% | 6.4分 |
| 34 | 艾迪药业 | 1.22% | 5.89% | 6.5分 |
| 36 | 上海莱士 | 0.75% | 0.00% | 5.7分 |
| 38 | 智飞生物 | -2.09% | 1.98% | 5.5分 |
| 40 | ST未名 | -4.05% | 3.17% | 4.6分 |
| 42 | 欧林生物 | -5.21% | 8.90% | 7.0分 |
| 44 | 君实生物 | -5.63% | 6.86% | 6.2分 |
| 46 | 百奥泰 | -6.22% | 3.30% | 6.0分 |
| 48 | 智翔金泰 | -7.45% | 7.33% | 5.5分 |
| 50 | 康弘药业 | -8.42% | 4.80% | 5.6分 |
| 52 | 特宝生物 | -12.73% | 1.84% | 5.8分 |
| 54 | 诺诚健华 | -15.33% | 9.46% | 5.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 23/72 ， 40/72。
[{"date":"2025-09-30","value":"4.48","vol":"-9.95"},{"date":"2025-06-30","value":"2.98","vol":"-0.61"},{"date":"2025-03-31","value":"1.12","vol":"0.46"},{"date":"2024-12-31","value":"9.71","vol":"-0.68"},{"date":"2024-09-30","value":"7.11","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.48 | 2.98 | 1.12 | 9.71 | 7.11 |
| 行业(%) | -9.95 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"46.32","vol":"67.19"},{"date":"2025-06-30","value":"47.63","vol":"68.28"},{"date":"2025-03-31","value":"48.06","vol":"68.43"},{"date":"2024-12-31","value":"49.13","vol":"69.85"},{"date":"2024-09-30","value":"50.52","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
46.32 | 47.63 | 48.06 | 49.13 | 50.52 |
| 行业(%) | 67.19 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 42/72 ， 36/72。
[{"date":"2025-09-30","value":"-14.40","vol":"44.96"},{"date":"2025-06-30","value":"-13.18","vol":"6902.04"},{"date":"2025-03-31","value":"-14.00","vol":"6125.27"},{"date":"2024-12-31","value":"14.00","vol":"47.35"},{"date":"2024-09-30","value":"37.49","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.40 | -13.18 | -14.00 | 14.00 | 37.49 |
| 行业(%) | 44.96 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-34.19","vol":"44.17"},{"date":"2025-06-30","value":"-27.89","vol":"5.44"},{"date":"2025-03-31","value":"-26.95","vol":"-8.46"},{"date":"2024-12-31","value":"21.76","vol":"-9.81"},{"date":"2024-09-30","value":"66.38","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-34.19 | -27.89 | -26.95 | 21.76 | 66.38 |
| 行业(%) | 44.17 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 28/72 ， 32/72。
[{"date":"2025-09-30","value":"0.17","vol":"0.22"},{"date":"2025-06-30","value":"0.11","vol":"0.14"},{"date":"2025-03-31","value":"0.04","vol":"0.06"},{"date":"2024-12-31","value":"0.30","vol":"0.29"},{"date":"2024-09-30","value":"0.21","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.11 | 0.04 | 0.30 | 0.21 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.59","vol":"0.91"},{"date":"2025-06-30","value":"0.36","vol":"0.56"},{"date":"2025-03-31","value":"0.15","vol":"0.26"},{"date":"2024-12-31","value":"1.26","vol":"1.17"},{"date":"2024-09-30","value":"0.91","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.59 | 0.36 | 0.15 | 1.26 | 0.91 |
| 行业(次) | 0.91 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"15.23","vol":"1.99"},{"date":"2025-06-30","value":"-12.56","vol":"-1377.61"},{"date":"2025-03-31","value":"-30.92","vol":"-46.99"},{"date":"2024-12-31","value":"12.33","vol":"-11.33"},{"date":"2024-09-30","value":"15.21","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 15.23 | -12.56 | -30.92 | 12.33 | 15.21 |
| 行业 | 1.99 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.50","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.83","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.50 | - | 3.83 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 14/72 ， 15/72。
[{"date":"2025-09-30","value":"2.93","vol":"5.99"},{"date":"2025-06-30","value":"3.67","vol":"6.64"},{"date":"2025-03-31","value":"4.19","vol":"7.75"},{"date":"2024-12-31","value":"3.74","vol":"6.72"},{"date":"2024-09-30","value":"4.06","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.93 | 3.67 | 4.19 | 3.74 | 4.06 |
| 行业 | 5.99 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.56","vol":"4.82"},{"date":"2025-06-30","value":"1.87","vol":"5.30"},{"date":"2025-03-31","value":"2.37","vol":"6.35"},{"date":"2024-12-31","value":"2.42","vol":"5.40"},{"date":"2024-09-30","value":"2.70","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.56 | 1.87 | 2.37 | 2.42 | 2.70 |
| 行业 | 4.82 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 31/72 ， 31/72。
[{"date":"2025-09-30","value":"16.25","vol":"28.14"},{"date":"2025-06-30","value":"13.04","vol":"26.73"},{"date":"2025-03-31","value":"12.94","vol":"26.03"},{"date":"2024-12-31","value":"14.37","vol":"25.81"},{"date":"2024-09-30","value":"13.57","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.25 | 13.04 | 12.94 | 14.37 | 13.57 |
| 行业(%) | 28.14 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.19","vol":"0.58"},{"date":"2025-06-30","value":"0.15","vol":"1.11"},{"date":"2025-03-31","value":"0.15","vol":"0.78"},{"date":"2024-12-31","value":"0.17","vol":"0.87"},{"date":"2024-09-30","value":"0.16","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.19 | 0.15 | 0.15 | 0.17 | 0.16 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国泰海通证券 | 2025-09-09 | 买入 | |
| 中信证券 | 2025-09-05 | 买入 | |
| 东方证券 | 2025-09-02 | 买入 | |
| 野村东方国际证券 | 2025-08-27 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.45","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.44","blueLineValue":"0.89","type":"YC"}]